July 19, 2018 Lilly’s Once-Weekly Trulicity® (dulaglutide) Label Updated to Include Data Showing Benefits for Adults with Type 2 Diabetes and Chronic Kidney Disease INDIANAPOLIS, July 19, 2018 /PRNewswire/ — The U.S. label for Eli Lilly and Company’s (NYSE: LLY) once-weekly
Lilly’s Once-Weekly Trulicity® (dulaglutide) Label Updated to Include Data Showing Benefits for Adults with Type 2 Diabetes and Chronic Kidney Disease
